Severe Pneumocystis jirovecii pneumonia: time to reassess our practices
- PMID: 39073581
- DOI: 10.1007/s00134-024-07547-9
Severe Pneumocystis jirovecii pneumonia: time to reassess our practices
References
-
- Kamel T, Boulain T (2024) Pneumocystis pneumonia in French intensive care units in 2013–2019: mortality and immunocompromised conditions. Ann Intensive Care [Internet]. Ann Intensive Care. https://pubmed.ncbi.nlm.nih.gov/38776012/ . Accessed 30 May 2024
-
- Bongomin F, Gago S, Oladele RO, Denning DW (2017) Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi 3:57 - DOI
-
- Maschmeyer G, Helweg-Larsen J, Pagano L, Robin C, Cordonnier C, Schellongowski P. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients; 7 Intensive Care in Hematologic and Oncologic Patients (iCHOP). www.kobe.fr/ecil . Accessed 1 June 2024.
-
- Giacobbe DR, Dettori S, Di PV, Asperges E, Ball L, Berti E et al (2024) RESEARCH open access Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG. Adolfo González Sáez [Internet]. 19:34
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources